Metadoxil

Metadoxine, the active ingredient in Metadoxil, is a hepatoprotective agent presented as an oral tablet for oral use. It treats alcoholic liver disease, hepatic encephalopathy and liver cirrhosis in adult patients.

GNH USA supplies Metadoxil as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Metadoxil is used in the management of liver disease conditions where hepatic function is compromised.

- Alcoholic liver disease: improves liver enzyme levels and supports recovery of hepatic function. - Hepatic encephalopathy: reduces neurotoxic ammonia accumulation and helps restore mental status. - Liver cirrhosis: aids in stabilizing liver function and may delay progression of fibrosis.

Metadoxil may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Headache: transient mild headache. - Dizziness: occasional light‑headedness. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Hepatic failure: worsening liver function. - Severe allergic reaction: rash, swelling, anaphylaxis. - Blood dyscrasias: neutropenia or thrombocytopenia. - Pancreatitis: abdominal pain with elevated enzymes.

When prescribing Metadoxil, clinicians should consider several precautionary measures to ensure safe use.

- Liver function monitoring: assess baseline and periodic liver enzymes. - Alcohol abstinence: patients should avoid alcohol to maximize benefit. - Renal function: evaluate kidney status in patients with impairment. - Concomitant hepatotoxic drugs: avoid or monitor closely. - Pregnancy and lactation: use only if potential benefit justifies risk. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Metadoxil can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP450 inducers: may reduce Metadoxil effectiveness. - High-dose paracetamol: increased risk of hepatotoxicity.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): may enhance bleeding risk. - Other hepatoprotective agents: monitor liver function for additive effects. - Diuretics: watch for electrolyte disturbances.